Sascha Goonewardena

goonewardena-sascha
Associate Professor of Internal Medicine, Medical School
Email:
[email protected]
Available to mentor
Sascha Goonewardena
goonewardena-sascha
Associate Professor
  • About
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Manage Your Profile

  • About

    I am an Associate Professor of Medicine, the Associate Director of the Vascular Defense and Discovery Laboratory, and the inaugural Wolfe Immunocardiology Scholar in the Division of Cardiovascular Medicine at the University of Michigan. My research focuses on translational studies and the basic mechanisms of innate immune responses, including how innate immune cells respond to endogenous stress, how they modulate their responses in a context-dependent manner, and the molecular interactions between immune and non-immune cells during the initiation of inflammatory responses. I completed a postdoctoral fellowship at the University of Chicago, using murine models and systems biology approaches to elucidate the innate immune mechanisms underlying heart failure. As an NIH T32 postdoctoral fellow and during my K08 award (NIH/NHLBI), I employed multidimensional cytometry and bioinformatics (including transcriptomics, metabolomics, and proteomics) to investigate innate immune mechanisms behind chronic inflammatory diseases. Over the past several years, I have used cellular, molecular, and machine learning techniques to understand the immune mechanisms driving cardiometabolic disease. My lab has built on these concepts and technologies, utilizing RNA-seq, various proteomic platforms, flow/mass cytometry, and bioinformatics to study how immune dysfunction accelerates thrombotic and cardiovascular diseases. I also serve as the Principal Investigator on a CSR&D Merit award, an investigator-initiated industry contract in which I use a microfluidic proteomic platform I developed to examine circulating immune phenotypes in patients treated with a PCSK9 inhibitor. Additionally, I am a reviewer for high-impact medical journals and an associate editor of the Journal of Clinical Lipidology and Cardiovascular Drugs and Therapeutics, with over 70 manuscripts published.

    Qualifications

    • Residency
      University of Chicago Hospital, Internal Medicine, Chicago IL, United States
      2004 - 2026
    • Postdoctoral Research Fellow
      University of Michigan–Ann Arbor, Immunology and Nanotechnology, Ann Arbor, United States
      2009 - 2011
    • Fellowship
      University of Michigan–Ann Arbor, Cardiovascular Medicine, Ann Arbor, United States
      2007 - 2009
    • Postdoctoral Research Fellow
      University of Chicago Medical Center, Genomics/systems biology, Chicago, United States
      2006 - 2007
    • Internship
      University of Chicago Hospitals, Internal Medicine, Chicago, IL, United States
      2003 - 2004

    Center Memberships

    • Center Member
      Taubman Institute
    • Center Member
      Samuel and Jean Frankel Cardiovascular Center

    Research Overview

    Innate immunity and macrophage biolog
    Heart Failure and Atherosclerotic Cardiovascular Disease
    Vascular Biology

    Recent Publications

    See All Publications
    • Journal Article
      Deep and durable lipoprotein(a) lowering: Kylo-11 advances RNA interference therapeutics
      Rosenson RS, Goonewardena SN. Lancet, 2026 Sep 5; 408 (10558): 868 - 869. DOI:10.1016/S0140-6736(26)01639-9
      PMID: 42664980
    • Journal Article
      ID: 4567170 SCALING LAWS IN ECG FOUNDATION MODELS: PRE-TRAINING DATA VOLUME DRIVES PERFORMANCE GAINS ACROSS RHYTHM, FORM, DIAGNOSIS, AND STRUCTURAL HEART DISEASE TASKS
      Sriram R, Wood IN, Shahrabani E, Goonewardena S, Yao S, Gundl L, Loring Z, Murthy VL. Heart Rhythm O2, 2026 Sep 21; 7 (9): s58 DOI:10.1016/j.hroo.2026.08.098
    • Journal Article
      Lipoprotein(a) and Coronary Atherosclerosis: Does Risk Travel Through Plaque Burden, Plaque Vulnerability, or Both?
      Rosenson RS, Goonewardena SN. Jacc Cardiovascular Imaging, 2026 Sep 1; 19 (9): 1120 - 1121. DOI:10.1016/j.jcmg.2026.07.009
      PMID: 42710998
    • Journal Article
      From Prognosis to Therapy: suPAR and the Inflammatory Frontier in Heart Failure
      GOONEWARDENA SN, AZUBUIKE-OSU SO. Journal of Cardiac Failure, 2026 Aug 1; 32 (8): 1373 - 1375. DOI:10.1016/j.cardfail.2026.05.006
      PMID: 42263932
    • Journal Article
      LIPOPROTEIN(A) LOWERING AND RISK OF CARDIOVASCULAR DISEASE IN PRIMARY AND SECONDARY PREVENTION
      Thomas P, Nielsen S, Goonewardena S, Nordestgaard B, Rosenson R, Kamstrup P. Atherosclerosis, 2026 Sep 10; 419: 121697 DOI:10.1016/j.atherosclerosis.2026.121697
    • Journal Article
      Proteomic signatures as biomarkers of atherosclerosis burden
      Zhang L, Omarov M, Xu LL, Das B, Luo H, Hauck SM, Petrera A, Yu Z, Goonewardena SN, Zeggini E, Peters A, Dichgans M, Murthy VL, Thorand B, Georgakis MK. Cardiovascular Research, 2026 Aug 1; 122 (12): 1589 - 1608. DOI:10.1093/cvr/cvag140
      PMID: 42367007
    • Preprint
      Scaling ECG Foundation Models and Identifying a Threshold for Effective Representation Learning.
      Sriram R, Nenadic I, Shahrabani E, Goonewardena SN, Yao S, Farrell B, Loring Z, Murthy VL. 2026 Jul 17; DOI:10.64898/2026.07.15.26358182
      PMID: 42528512
    • Journal Article
      Inclisiran in CKD: A Therapeutic Answer to a Persistent Treatment Gap
      Goonewardena SN, Rosenson RS. Journal of the American Society of Nephrology, 2026 Jul 1; 37 (7): 1376 - 1378. DOI:10.1681/ASN.0000001127
      PMID: 42160189

    Featured News & Stories

    heart on monitor heart symbol black background neon red lines
    Health Lab

    AI model helps diagnose often undetected heart disease from simple EKG

    Michigan Medicine doctors may soon be able to diagnose an elusive form of heart disease within seconds by using an artificial intelligence model.